The Pharmasyntez Group is a Russian pharmaceutical company, which is engaged in development and production of up-to-date, high quality, and affordable medicines. It has been at the pharmaceutical market since 1997. The company activities are focused on development and production of pharmaceuticals meant for the treatment of socially significant diseases, such as tuberculosis, HIV/AIDS, oncology, diabetes mellitus, hepatitis, and blood diseases.